Siemens celebrates $2 million in donations to Cystic Fibrosis Canada
Longstanding partnership helps Canadians living with cystic fibrosis
TORONTO (June 27, 2019) – Today, Siemens celebrates the milestone of $2 million in accumulative giving over the course of its more than 20 year partnership with Cystic Fibrosis Canada. Every June, the company runs a fundraising campaign to support cystic fibrosis (CF) research, advocacy and care.
In its history with Cystic Fibrosis Canada, Siemens has supported the annual Walk to Make Cystic Fibrosis History, hosted fundraising events including the Siemens annual hockey tournament and soccer tournament, now in its 11th year, and encourages employees to give back through its corporate matching program. Siemens employees across Canada shine in June when they participate in a month-long fundraising campaign for Cystic Fibrosis Canada, including raffles, bake sales and yoga classes.
“This $2 million fundraising milestone speaks to the enthusiasm of thousands of Siemens employees across Canada who have supported our campaigns for more than two decades,” says Faisal Kazi, Siemens Canada CEO. “The courage and aspirations of Canadians living with CF continues to inspire us and we’re honoured to help fund the vital work of Cystic Fibrosis Canada on their behalf.”
Siemens and Cystic Fibrosis Canada partnered in 1997 when the company sponsored the Breath of Life Ski Challenge, founded by two time Olympian ski racer and Cystic Fibrosis Canada champion, Ken Read. It was the stories of CF community members like Ken and his nephew Andrew’s fight with CF that first caught the attention Siemens.
“We are incredibly proud to celebrate this achievement from our friends at Siemens,” said Kelly Grover, President and Chief Executive Officer at Cystic Fibrosis Canada. “The commitment and passion of the employees at Siemens is remarkable and we simply could not do the work we do without the dedication of our longstanding partners”.
More than 4,300 people in Canada live with cystic fibrosis, the most common fatal genetic disease among children and young adults in Canada, at present there is no cure. Cystic Fibrosis Canada funds specialized CF care, advocacy and leading-edge research.
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults. It is a multi-system progressive disease that affects mainly the lungs and the digestive system. In the lungs, where the effects are most devastating, a build-up of thick mucus leads to progressive loss of respiratory function. Mucus also builds up in the digestive tract, making it difficult to digest and absorb nutrients from food. As improved therapies have helped to address the malnutrition issues, ultimately most deaths related to cystic fibrosis are due to lung failure. There is no cure.
Cystic Fibrosis Canada
Cystic Fibrosis Canada is one of the world’s leading charitable organizations committed to finding a cure for cystic fibrosis and is an internationally-recognized leader in funding CF research, innovation, and clinical care. We invest more funding in life-saving CF research and care than any other non-governmental agency in Canada. Since 1960, Cystic Fibrosis Canada has invested more than $261 million in leading research, care and advocacy, resulting in one of the world’s highest survival rates for Canadians living with cystic fibrosis. For more information, visit cysticfibrosis.ca.
For more information, contact:
Nicole Young, Director, Corporate Communications
Cystic Fibrosis Canada
Tel: 416-485-9149 ext. 235
Tel: 1-800-378-2233 ext. 235
Back to Listing